NCT03034018View on ClinicalTrials.gov

Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 25, 2017

Primary Completion Date

April 3, 2020

Study Completion Date

April 3, 2020

Conditions
Insomnia
Interventions
DRUG

suvorexant

10-20 mg taken at bedtime for four weeks

DRUG

placebo

placebo taken at bedtime for four weeks

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT03034018 - Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia | Biotech Hunter | Biotech Hunter